1 |
Lambrecht B N, Hammad H. The immunology of asthma[J]. Nature Immunology, 2015, 16(1): 45-56.
|
2 |
Papi A, Brightling C, Pedersen S E, et al. Asthma[J]. The Lancet, 2018, 391(10122): 783-800.
|
3 |
Barnes P J. Cellular and molecular mechanisms of asthma and COPD[J]. Clinical Science (London, England), 2017, 131(13): 1541-1558.
|
4 |
Ortega V E, Meyers D A, Bleecker E R. Asthma pharmacogenetics and the development of genetic profiles for personalized medicine[J]. Pharmacogenomics and Personalized Medicine, 2015, 8: 9-22.
|
5 |
Spergel J M, Paller A S. Atopic dermatitis and the atopic March[J]. Journal of Allergy and Clinical Immunology, 2003, 112(6): S118-S127.
|
6 |
Russell R, Brightling C. Mepolizumab for the reduction of exacerbations in severe eosinophilic asthma[J]. Expert Review of Respiratory Medicine, 2016, 10(6): 607-617.
|
7 |
Chung K F, Wenzel S E, Brozek J L, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma[J]. The European Respiratory Journal, 2014, 43(2): 343-373.
|
8 |
Schleich F N, Manise M, Sele J, et al. Distribution of sputum cellular phenotype in a large asthma cohort: predicting factors for eosinophilic vs neutrophilic inflammation[J]. BMC Pulmonary Medicine, 2013, 13: 11.
|
9 |
Leyden E. Zur kenntniss des bronchial-asthma[J]. Archiv Für Pathologische Anatomie Und Physiologie Und Für Klinische Medicin, 1872, 54(4): 324-344.
|
10 |
Katzenstein A L A, Sale S R, Greenberger P A. Allergic Aspergillus sinusitis: a newly recognized form of sinusitis[J]. Journal of Allergy and Clinical Immunology, 1983, 72(1): 89-93.
|
11 |
Samter M. Charcot-Leyden crystals: a study of the conditions necessary for their formation[J]. Journal of Allergy, 1947, 18(4): 221-230.
|
12 |
Chua J C, Douglass J A, Gillman A, et al. Galectin-10, a potential biomarker of eosinophilic airway inflammation[J]. PLoS One, 2012, 7(8): e42549.
|
13 |
Persson E K, Verstraete K, Heyndrickx I, et al. Protein crystallization promotes type 2 immunity and is reversible by antibody treatment[J]. Science, 2019, 364(6442): eaaw4295.
|
14 |
Covar R A. Pivotal efficacy trials of inhaled corticosteroids in asthma[J]. Annals of Allergy, Asthma & Immunology, 2016, 117(6): 582-588.
|